WFNMB2022/JSNM2022/JSNMT2022

Presentation information

Print

[JSNM]Radiopharmaceuticals3: Therapy2

Annual Scientific Meeting of the Japanese Society of Nuclear Medicine Program » [核医学]一般演題 口演

Radiopharmaceuticals3

Therapy2

Sat. Sep 10, 2022 11:00 AM - 12:00 PM Room6 (Kyoto International Conference Center 2F RoomB-2)

Chair：Izumi Umeda (Kavli Ipmu, Tokyo University), Yasuhiro Magata (Hamamatsu University School Of Medicine)

[M2VIB3] Silencing of the deubiquitinase OTUB1 inhibits cytotoxicity of 211At-MABG

Yasuhiro Ohshima1、Tetsuya Sakashita1、Yuichiro Yokota1、Ichiro Sasaki1、Shigeki Watanabe1、Nobuaki Kono2、Kazuharu Arakawa2,3、Noriko Ishioka1 (1.Department of Radiation-Applied Biology Research, Takasaki Advanced Radiation Research Institute, National Institutes for Quantum Science and Technology, Takasaki, Japan、2.Institute for Advanced Biosciences, Keio University, Yamagata, Japan、3.Faculty of Environment and Information Studies, Keio University, Kanagawa, Japan)

Abstract password authentication.The password is described on page 8 of the "WFNMB2022 Program"

Password